Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
T Stamp A | IDAI | 28. mar 2024 | 0.92 | -1.71 |
T-Mobile US | TMUS | 28. mar 2024 | 163.22 | +0.75 |
T. Rowe Price Blue Chip Growth ETF | TCHP | 28. mar 2024 | 35.30 | -0.14 |
T. Rowe Price Dividend Growth ETF | TDVG | 28. mar 2024 | 38.00 | 0.00 |
T. Rowe Price Equity Income ETF | TEQI | 28. mar 2024 | 39.64 | +0.33 |
T. Rowe Price Group | TROW | 28. mar 2024 | 121.92 | +0.88 |
T. Rowe Price Growth Stock ETF | TGRW | 28. mar 2024 | 34.39 | -0.01 |
T2 Biosystems | TTOO | 28. mar 2024 | 3.00 | -1.64 |
Taboola.com | TBLA | 28. mar 2024 | 4.44 | +0.91 |
Tactile Systems Technology | TCMD | 28. mar 2024 | 16.25 | +2.46 |
Taitron Components A | TAIT | 28. mar 2024 | 3.26 | -0.01 |
Taiwan Fund | TWN | 28. mar 2024 | 39.62 | -0.31 |
Taiwan Index MSCI Ishares | EWT | 28. mar 2024 | 48.68 | +0.19 |
Taiwan Semiconductor Manufacturing ADR | TSM | 28. mar 2024 | 136.05 | -0.47 |
Take-Two Interactive Software | TTWO | 28. mar 2024 | 148.49 | +1.07 |
Takeda Pharmaceutical ADR | TAK | 28. mar 2024 | 13.89 | -2.11 |
TAL Education Group ADR | TAL | 28. mar 2024 | 11.35 | +0.80 |
Talis Biomedical | TLIS | 28. mar 2024 | 8.75 | -1.41 |
Talkspace | TALK | 28. mar 2024 | 3.57 | 0.00 |
Talos Energy | TALO | 28. mar 2024 | 13.93 | +2.05 |
Talphera | TLPH | 28. mar 2024 | 1.03 | 0.00 |
Tandem Diabetes Care | TNDM | 28. mar 2024 | 35.41 | +0.31 |
Tanger | SKT | 28. mar 2024 | 29.53 | -0.07 |
Tango Therapeutics | TNGX | 28. mar 2024 | 7.94 | +3.12 |
Tantech | TANH | 28. mar 2024 | 0.66 | -4.30 |
Taoping | TAOP | 28. mar 2024 | 1.09 | 0.00 |
Tapestry | TPR | 28. mar 2024 | 47.48 | +1.71 |
Targa Resources | TRGP | 28. mar 2024 | 111.99 | +0.85 |
Target | TGT | 28. mar 2024 | 177.21 | +1.45 |
Target Global Acquisition I A | TGAA | 28. mar 2024 | 11.19 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.